Notice: This company has been marked as potentially delisted and may not be actively trading. GX Acquisition (GXGX) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends GXGX vs. CHPM, ALUS, SOAC, KALV, RVNC, LRMR, AKBA, TNGX, VERV, and CTNMShould you be buying GX Acquisition stock or one of its competitors? The main competitors of GX Acquisition include CHP Merger (CHPM), Alussa Energy Acquisition (ALUS), Sustainable Opportunities Acquisition (SOAC), KalVista Pharmaceuticals (KALV), Revance Therapeutics (RVNC), Larimar Therapeutics (LRMR), Akebia Therapeutics (AKBA), Tango Therapeutics (TNGX), Verve Therapeutics (VERV), and Contineum Therapeutics (CTNM). GX Acquisition vs. CHP Merger Alussa Energy Acquisition Sustainable Opportunities Acquisition KalVista Pharmaceuticals Revance Therapeutics Larimar Therapeutics Akebia Therapeutics Tango Therapeutics Verve Therapeutics Contineum Therapeutics GX Acquisition (NASDAQ:GXGX) and CHP Merger (NASDAQ:CHPM) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, earnings, institutional ownership, valuation, community ranking, dividends, profitability and media sentiment. Do institutionals & insiders hold more shares of GXGX or CHPM? 61.7% of GX Acquisition shares are owned by institutional investors. Comparatively, 71.7% of CHP Merger shares are owned by institutional investors. 20.0% of CHP Merger shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Is GXGX or CHPM more profitable? CHP Merger's return on equity of -245.62% beat GX Acquisition's return on equity.Company Net Margins Return on Equity Return on Assets GX AcquisitionN/A -985.20% -6.02% CHP Merger N/A -245.62%8.11% Does the media favor GXGX or CHPM? In the previous week, GX Acquisition's average media sentiment score of 0.00 equaled CHP Merger'saverage media sentiment score. Company Overall Sentiment GX Acquisition Neutral CHP Merger Neutral Does the MarketBeat Community favor GXGX or CHPM? GX Acquisition received 2 more outperform votes than CHP Merger when rated by MarketBeat users. CompanyUnderperformOutperformGX AcquisitionOutperform Votes2100.00% Underperform VotesNo VotesCHP MergerN/AN/A Which has more risk & volatility, GXGX or CHPM? GX Acquisition has a beta of 0.17, meaning that its share price is 83% less volatile than the S&P 500. Comparatively, CHP Merger has a beta of 0.05, meaning that its share price is 95% less volatile than the S&P 500. Which has preferable valuation and earnings, GXGX or CHPM? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGX AcquisitionN/AN/A-$49.26MN/AN/ACHP MergerN/AN/A$22.22MN/AN/A SummaryCHP Merger beats GX Acquisition on 5 of the 7 factors compared between the two stocks. Ad WealthPressThis Bull Market Indicator called NVDA at $116Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…All you have to do is follow this link here Get GX Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for GXGX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GXGX vs. The Competition Export to ExcelMetricGX AcquisitionPharmaceutical Preparations IndustryMedical SectorNASDAQ ExchangeMarket Cap$102.42M$6.58B$5.15B$8.84BDividend YieldN/A8.11%5.06%4.07%P/E RatioN/A10.97126.3517.61Price / SalesN/A363.551,230.6086.42Price / CashN/A52.5940.1936.27Price / Book20.3610.176.936.36Net Income-$49.26M$153.36M$119.54M$225.88M GX Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GXGXGX AcquisitionN/A$2.85-3.1%N/A+1,291.8%$102.42MN/A0.00N/ACHPMCHP MergerN/A$10.18flatN/A+0.0%$265.81MN/A0.003ALUSAlussa Energy AcquisitionN/A$9.50flatN/A+0.0%$341.41MN/A-3.141Gap UpSOACSustainable Opportunities AcquisitionN/A$10.62flatN/A+0.0%$398.25MN/A0.003KALVKalVista Pharmaceuticals3.754 of 5 stars$9.28+3.5%$26.00+180.3%+9.1%$400.87MN/A-2.63150Insider TradeNews CoverageRVNCRevance Therapeutics4.0842 of 5 stars$3.84+1.1%$9.66+151.5%-49.1%$398.63M$256.95M-1.99597Analyst ForecastLRMRLarimar Therapeutics3.6986 of 5 stars$6.13+0.8%$20.43+233.3%+93.6%$391.16MN/A-5.3330Analyst ForecastAKBAAkebia Therapeutics3.9538 of 5 stars$1.82+1.7%$5.75+215.9%+75.5%$390.54M$169.88M-7.91167TNGXTango Therapeutics2.5243 of 5 stars$3.63-11.0%$13.14+262.1%-46.4%$389.94M$36.53M-3.1590High Trading VolumeVERVVerve Therapeutics2.4495 of 5 stars$4.60+1.1%$25.75+459.8%-63.2%$389.44M$11.76M-1.87110CTNMContineum Therapeutics1.6507 of 5 stars$14.34+5.1%$29.25+104.0%N/A$369.69M$50M0.0031 Related Companies and Tools Related Companies CHPM Competitors ALUS Competitors SOAC Competitors KALV Competitors RVNC Competitors LRMR Competitors AKBA Competitors TNGX Competitors VERV Competitors CTNM Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:GXGX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GX Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share GX Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.